Ngā hua rapu - Debby Long
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors mā Kevin C. Conlon, Dionysios C. Watson, Thomas A. Waldmann, Antonio Valentin, Cristina Bergamaschi, Barbara K. Felber, Cody J. Peer, William D. Figg, E. Lake Potter, Mario Roederer, Douglas G. McNeel, John A. Thompson, Sumati Gupta, Rom S. Leidner, Andrea Wang‐Gillam, Nehal S. Parikh, Debby Long, Sema Kurtuluş, Lang Ho Lee, Niladri Roy Chowdhury, Florent C. Bender, George N. Pavlakis
I whakaputaina 2021Artigo -
2
Long-acting protein drugs for the treatment of ocular diseases mā Joy G. Ghosh, Andrew Nguyen, Chad E. Bigelow, Stephen Poor, Yubin Qiu, Nalini Rangaswamy, Richard Ornberg, B. Jackson, Howard Mak, Tucker Ezell, Vania Kenanova, Elisa De La Cruz, Ana Carrión, Bijan Etemad-Gilbertson, Roxana García, Kan Zhu, Vinney George, Jirong Bai, Radhika Sharma-Nahar, Siyuan Shen, Yiqin Wang, Kulandayan K. Subramanian, Elizabeth Fassbender, Michael Maker, Shawn Hanks, Joanna Vrouvlianis, Barrett Leehy, Debby Long, Melissa Prentiss, Viral Kansara, Bruce Jaffee, Thaddeus P. Dryja, Michael Roguska
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biochemistry
Biology
Cancer research
Medicine
Pharmacology
Aflibercept
Agonist
Bevacizumab
Bioinformatics
Chemistry
Chemotherapy
Dosing
Gene
Internal medicine
Macular degeneration
Oncology
Ophthalmology
Peptide
Ranibizumab
Receptor
Recombinant DNA
Retinal
Surgery
VEGF receptors
Vascular endothelial growth factor
Vascular endothelial growth factor A